Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing
THE EFFECT OF WEB-BASED EDUCATION GIVEN TO WOMEN ON THEIR ATTITUDES AND BELIEFS ABOUT HPV TESTING
1 other identifier
interventional
120
0 countries
N/A
Brief Summary
Cervical cancer is a highly preventable public health issue that significantly impacts women's quality of life. Although effective screening programs such as Human Papilloma Virus (HPV) testing and Pap-smears are widely available, women's participation in these early detection services often remains limited. The primary barriers to screening attendance include insufficient education, lack of information, negative beliefs, psychosocial or cultural factors, and misconceptions regarding gynecological examinations. To improve screening uptake, health interventions must focus not only on increasing knowledge but also on promoting correct beliefs and positive attitudes toward testing. Web-based health education serves as an effective method to overcome barriers such as cost, transportation difficulties, and geographical limitations, allowing wider access to healthcare guidance. This study aims to evaluate the effects of a specialized web-based educational intervention on women's attitudes and beliefs regarding the HPV test. The research is designed as a randomized controlled trial with a pre-test and post-test design. Participants will be assigned to either an intervention group or a control group. The intervention group will receive structured health education through a dedicated web platform, while the control group will receive routine standard follow-up. Data will be gathered using a specific attitude and belief scale before and after the application to measure the intervention's impact.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2026
CompletedFirst Posted
Study publicly available on registry
June 2, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
Study Completion
Last participant's last visit for all outcomes
September 1, 2026
June 2, 2026
May 1, 2026
2 months
May 20, 2026
May 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Personal Barriers Subscale
This subscale consists of 7 items (items 1-7) assessing personal barriers, stigma, and shame related to HPV testing. Scores range from 7 to 49. A higher score indicates a higher level of perceived personal barriers, meaning a less favorable attitude toward HPV testing.
Baseline and 12 weeks post-intervention
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Social Norms Subscale
This subscale consists of 4 items (items 8-11) assessing the influence of friends, partners, family, and social media on HPV testing. Scores range from 4 to 28. A higher score indicates higher negative social pressure/barriers, meaning a lower level of favorable attitudes and beliefs
Baseline and 12 weeks post-intervention
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Trust Subscale
This subscale consists of 6 items (items 12-17) assessing trust in the healthcare system, accuracy of HPV testing, and medical procedures. Scores range from 6 to 42. A higher score indicates higher levels of perceived benefit, confidence, and trust toward HPV testing.
Baseline and 12 weeks post-intervention
Attitudes and Beliefs About HPV Testing Scale (ABHTS) - Concerns Subscale
This subscale consists of 3 items (items 18-20) assessing concerns and worries related to the process and outcomes of HPV testing. Scores range from 3 to 21. A higher score indicates higher levels of concerns/negative attitudes toward HPV testing.
Baseline and 12 weeks post-intervention
Study Arms (2)
Intervention Group
EXPERIMENTALParticipants in this group will receive access to the web-based health education platform developed for the study.
control group
NO INTERVENTIONParticipants in this group will receive standard routine follow-up during the study. After the completion of the study data collection, the web-based health education platform will also be made accessible to this group.
Interventions
Participants in the intervention group will receive health education through a specially designed web-based platform containing 11 presentations in total (8 PowerPoint presentations, 1 animation video explaining how the HPV test is performed, and 1 researcher-led instructional video demonstrating self-vulvar examination on a model). Participants will also be provided with educational brochures and magnets. For participants who do not view the presentations, weekly reminder text messages will be sent to encourage platform login and module completion.
Eligibility Criteria
You may qualify if:
- Having no prior clinical diagnosis of cervical cancer
- Being between 18 and 60 years of age
- Having active access to the internet
- Being literate at a level sufficient to read and understand the questionnaire forms
- Being capable of effectively navigating and using a web browser
- Being registered as a patient at Sakarya Akyazı No. 3 Family Health Center
- Volunteering to participate in the study and providing informed consent
You may not qualify if:
- Withdrawing from the study voluntarily at any stage
- Failing to watch the mandatory educational videos on the platform
- Submitting incomplete or incorrect responses to the data collection tools
- Lacking active internet access or proper web browser usage skills
- Criteria for Study Discontinuation / Drop-out:
- Participant's request to withdraw from the study
- Failure to respond to or complete the data collection tools
- Not using or logging into the web application for more than 2 consecutive weeks during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
ZEKİYE TURAN, Phd, Associate Professor
Sakarya University Faculty of Health Sciences
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Phd Candidate, Department of Midwifery
Study Record Dates
First Submitted
May 20, 2026
First Posted
June 2, 2026
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
September 1, 2026
Last Updated
June 2, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared to ensure and maintain participant confidentiality in accordance with the institutional ethics committee approval and local data protection regulations.